UA31637A - METHOD OF FORECASTING LATE GESTOSIS IN PREGNANT WOMEN - Google Patents
METHOD OF FORECASTING LATE GESTOSIS IN PREGNANT WOMENInfo
- Publication number
- UA31637A UA31637A UA98105252A UA98105252A UA31637A UA 31637 A UA31637 A UA 31637A UA 98105252 A UA98105252 A UA 98105252A UA 98105252 A UA98105252 A UA 98105252A UA 31637 A UA31637 A UA 31637A
- Authority
- UA
- Ukraine
- Prior art keywords
- pregnant women
- risk
- forecasting
- reaction
- late
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Винахід, відноситься до медицини, точніше до акушерства та гінекології. Спосіб прогнозування пізніх гестозів у вагітних жінок передбачає визначення факторів ризику пізніх гестозів. Проводять огляд вагітних, вимірюють зріст, вагу, розмір тазу, кров'яного тиску, термін вагітності, зміну стану під час вагітності, номер наступних пологів, дослідження аналізу крові - загальний, реакція Вассермана, резус-належність та група крові, реакція вірус імунодефіциту, загальний аналіз сечі, визначають прогостичні коефіцієнти. При значеннях від -119,9 до -60,0 вагітних жінок відносять до групи малого ризику, від -39,9 до 0 - до групи середнього ризику і від +0,1 до +69,9 включно - до групи підвищеного ризику.The invention relates to medicine, more specifically to obstetrics and gynecology. The method of predicting late preeclampsia in pregnant women involves determining the risk factors for late preeclampsia. Pregnant women are examined, height, weight, pelvic size, blood pressure, gestational age, pregnancy change, number of subsequent births, blood test - general, Wasserman's reaction, rhesus affiliation and blood group, immunodeficiency virus reaction, general analysis of urine, determine the progostic coefficients. At values from -119.9 to -60.0 pregnant women are classified as low-risk, from -39.9 to 0 - to medium risk and from +0.1 to +69.9 inclusive - to high risk.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA98105252A UA31637A (en) | 1998-10-06 | 1998-10-06 | METHOD OF FORECASTING LATE GESTOSIS IN PREGNANT WOMEN |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA98105252A UA31637A (en) | 1998-10-06 | 1998-10-06 | METHOD OF FORECASTING LATE GESTOSIS IN PREGNANT WOMEN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA31637A true UA31637A (en) | 2000-12-15 |
Family
ID=74283549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA98105252A UA31637A (en) | 1998-10-06 | 1998-10-06 | METHOD OF FORECASTING LATE GESTOSIS IN PREGNANT WOMEN |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA31637A (en) |
-
1998
- 1998-10-06 UA UA98105252A patent/UA31637A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Spencer | Screening for trisomy 21 in twin pregnancies in the first trimester using free β‐hCG and PAPP‐A, combined with fetal nuchal translucency thickness | |
| Ashoor et al. | Chromosome-selective sequencing of maternal plasma cell–free DNA for first-trimester detection of trisomy 21 and trisomy 18 | |
| Palomaki et al. | Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropin | |
| Kajii et al. | Banding analysis of abnormal karyotypes in spontaneous abortion. | |
| Spencer et al. | Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro‐Caribbean populations | |
| Benn et al. | Combined second-trimester biochemical and ultrasound screening for Down syndrome | |
| Dujardin et al. | The value of maternal height as a risk factor of dystocia: a meta‐analysis | |
| EP0447424A4 (en) | Isolation of fetal cells from maternal blood to enable prenatal diagnosis | |
| Martins et al. | Evaluation of demographic, clinical characteristics, and genetic polymorphism as risk factors for pelvic organ prolapse in Brazilian women | |
| Ladfors et al. | Prevalence and risk factors for prelabor rupture of the membranes (PROM) at or near term in an urban Swedish population | |
| JP2005017305A (en) | Prenatal screening for chromosomal abnormalities | |
| Beckman et al. | Placental alkaline phosphatase phenotypes and pre-natal selection: Evidence from studies of spontaneous and induced abortions | |
| Kürzl et al. | Prognostic factors in squamous cell carcinoma of the vulva: a multivariate analysis | |
| DE69332456D1 (en) | METHOD AND DEVICE FOR DETECTING THE DOWN SYNDROME BY NON-INVASIVE ANALYSIS OF MATERNAL BLOOD | |
| UA31637A (en) | METHOD OF FORECASTING LATE GESTOSIS IN PREGNANT WOMEN | |
| Thorburn et al. | Background factors of ectopic pregnancy. II. Risk estimation by means of a logistic model | |
| Frazier et al. | Follicle-stimulating hormone and estradiol levels independently predict the success of assisted reproductive technology treatment | |
| Garratt et al. | Assessing the endometrium: an update on current and potential novel biomarkers of receptivity | |
| Wald et al. | First trimester biochemical screening for Down's syndrome | |
| Kumar et al. | Inherited thrombophilia profile in patients with recurrent miscarriages: Experience from a tertiary care center in north India | |
| Dreyfus et al. | The prediction of preeclampsia: reassessment of clinical value of increased plasma levels of fibronectin | |
| Ahmed et al. | Estimation of gestational age by last menstrual period, by ultrasound scan and by SP1 concentration: comparisons with date of delivery | |
| Dux et al. | Renin, aldosterone, and serum-converting enzyme activity during normal and hypertensive pregnancy | |
| Doran et al. | Amniotic fluid testosterone and follicle-stimulating hormone assay in the prenatal determination of fetal sex | |
| Reindollar et al. | Prenatal diagnosis of 21-hydroxylase deficiency by the complementary deoxyribonucleic acid probe for cytochrome P-450C-21OH |